期刊文献+

曲美他嗪联合辛伐他汀治疗慢性心力衰竭疗效观察 被引量:3

Clinical observation of trlmetazldine combined with slmvastatin in treatment of chronic heart failure
原文传递
导出
摘要 目的研究曲芙他嗪联合辛伐他汀治疗慢性心力衰竭的疗效。方法选择夏邑县人民医院2009年1月至2012年1月收治的慢性心力衰竭患者120例,将其随机分为对照组和观察组,每组60例。对照组给予常规抗心力衰竭药物治疗,观察组患者临床给予曲芙他嗪联合辛伐他汀。测量患者治疗前后的左心室内径、左心室后壁厚度、电解质以及血糖、血脂变化,并进行对比分析。结果观察组患者的临床效果明显高于对照组。且左心室内径、左心室后壁厚度、室间隔厚度以及射血分数变化改变情况亦明显高于对照组,两组比较差异有统计学意义(P〈0.05)。结论曲芙他嘹联合辛伐他汀治疗慢性心力衰竭疗效明显,并且药效平稳,能够有效地提高患者的心肌收缩与舒张能力,使用安全可靠。 ObJective To study the effect of trimetazidine combined with simvastafin on chronic heart failure. Methods One hundred and twenty patients with chronic heart failure admitted in our hospital from January 2009 to January 2012 were randomly divided into control group and observation group, 60 cases in each group. The patients in control group were given routine anti-heart failure drug treatment, and the patients in observation group were given trimetazidine combined with simvastatin treatment. The left ventricular diameter, left ventricular posterior wall thickness, electrolytes and the serum levels of glu- cose and lipid before and after treatment were detected and analyzed. Results The clinical effect of ob- servation group were significantly higher than that of control group, and the left ventricular diameters, ventricular septal thickness, left ventricular posterior wall thickness as well as the ejection fraction chan- ges improved more significantly in the observation group than those in the control group, there were signif- icant differences ( P 〈 0.05 ). Conclusions Trimetazidine combined with simvastatin in the treatment of chronic heart failure has obvious effect, and the efficacy was smooth, can effectively improve the myocardial systolic and diastolic ability, and is safe and reliable.
作者 程向阳
出处 《中国实用医刊》 2012年第23期63-65,共3页 Chinese Journal of Practical Medicine
关键词 曲美他嗪 辛伐他汀 慢性心力衰竭 临床疗效 Trimetazidine Simvastatin Chronic heart failure Clinical efficacy
  • 相关文献

参考文献5

二级参考文献22

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 2Kaesemeyer WH, Caldwell RB, Huang J, et al..Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lwering actions[J]. J Am Coll Cardiol, 1999,33(1) :234.
  • 3Hernandez TL,Capell WH ,Wolfe P, et al. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus[J]. Am J Cardiol, 2006 ,98(12) : 1656.
  • 4Shargorodsky M, Hass E,Boaz M,et al. High dose treatment with angiotensin II receptor blocker in patients with hypertension:differential effect of tissue protection versus blood pressure lowering [J]. Atherosclerosis, 2008, 197 (1) :303.
  • 5Sicard P, Lauzier B,Oudot A, et al. A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats[J]. Arch Mal Coeur Vaiss, 2005,98 (7-8) : 804.
  • 6Cosentino F, Voljpe M. Hypertehsion, stroke, and endothelium[J]. Curr Hypertens Rep, 2005,7 ( 1 ) : 68.
  • 7Celermajer DS..Sorensen KE,Gooch VM, et al. Non inva sive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [J]. Lancet, 1992, 340 :1111.
  • 8Perticone F, Sciacqua A, Maio R, et al. A symmetric dimethylarginine, L-arginine, and endot helial dysfunction in essential hypertension[J].J Am Coll Cardiol, 2005, 46 (3):518.
  • 9Nickenig G, Sachinidis A, Michaelsen F, et al. Upregulation of vascular angiotensin-II receptor gene expression by low-density lipoproytein in vascular smooth muscule cells[J]. Circulation, 1997,95:473.
  • 10Niekenig G, Jung O , Strehlow K, et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-rreceptot expression[J]. Am J Physiol,1997,272. H2701.

同被引文献28

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部